Esther Hurwitz
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
- Radiopharmaceutical Chemistry and Applications
- Oncology top 5%
- HER2/EGFR in Cancer Research
Papers in
-
- Monoclonal and Polyclonal Antibodies Research 40
-
- Glycosylation and Glycoproteins Research 18
- Protein purification and stability 9
- Chemical Synthesis and Analysis 3
- Co-authors
- Michael Sela (34 shared papers)Ruth Arnon (12 shared papers)David M. Segal (4 shared papers)Yosef Yarden (5 shared papers)Meir Wilchek (11 shared papers)Ruth Maron (6 shared papers)Ilana Stancovski (5 shared papers)Joseph Haimovich (8 shared papers)
- Journals
- Proceedings of the National Academy of Sciences (7 papers)International Journal of Cancer (6 papers)Biochemistry (4 papers)JNCI Journal of the National Cancer Institute (3 papers)The Journal of Immunology (3 papers)
- Partner nations
- IsraelUnited StatesJapan
In The Last Decade
Esther Hurwitz
57 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 100
- Radiology, Nuclear Medicine and Imaging 1.4k
- Oncology 934
- Immunology 543
- Molecular Biology 1.4k
- Biotechnology 131
Countries citing papers authored by Esther Hurwitz
This map shows the geographic impact of Esther Hurwitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esther Hurwitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esther Hurwitz more than expected).
Fields of papers citing papers by Esther Hurwitz
This network shows the impact of papers produced by Esther Hurwitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esther Hurwitz. The network helps show where Esther Hurwitz may publish in the future.
Co-authors
The 25 scholars most cited alongside Esther Hurwitz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 58 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1986 | 207 | |
| 2 | The covalent binding of daunomycin and adriamycin to antibodies, with retention of both drug and antibody activities. | 1975 | 206 |
| 3 | 1988 | 198 | |
| 4 | 1991 | 180 | |
| 5 | 1977 | 167 | |
| 6 | 1997 | 157 | |
| 7 | 1995 | 132 | |
| 8 | 1978 | 104 | |
| 9 | Tumor-inhibitory monoclonal antibodies to the HER-2/Neu receptor induce differentiation of human breast cancer cells. | 1992 | 97 |
| 10 | The specific cytotoxic effects of daunomycin conjugated to antitumor antibodies. | 1975 | 89 |
| 11 | 1972 | 78 | |
| 12 | 1982 | 65 | |
| 13 | 1970 | 64 | |
| 14 | 1978 | 58 | |
| 15 | 1966 | 58 | |
| 16 | 1989 | 53 | |
| 17 | 1976 | 52 | |
| 18 | 1982 | 50 | |
| 19 | 1971 | 48 | |
| 20 | 1970 | 46 |
About Esther Hurwitz
Esther Hurwitz is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology, Oncology, Immunology and Organic Chemistry, having authored 58 papers that have together received 2.7k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (40 papers), Glycosylation and Glycoproteins Research (18 papers), HER2/EGFR in Cancer Research (12 papers), Protein purification and stability (9 papers), Toxin Mechanisms and Immunotoxins (5 papers), Cancer Research and Treatments (3 papers), Nanoparticle-Based Drug Delivery (3 papers) and Chemical Synthesis and Analysis (3 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (1.4k citations), Oncology (934 citations), Immunology (543 citations), Molecular Biology (1.4k citations) and Biotechnology (131 citations). Esther Hurwitz has collaborated with scholars based in Israel, United States and Japan. Frequent co-authors include Michael Sela, Ruth Arnon, David M. Segal, Yosef Yarden, Meir Wilchek, Ruth Maron, Ilana Stancovski, Joseph Haimovich, Yedy Israel and Ronald Levy. Their work appears in journals such as Proceedings of the National Academy of Sciences, International Journal of Cancer, Biochemistry, JNCI Journal of the National Cancer Institute and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.